Financials
- Market Capitalization 244.94 M
- Employee 7
- Founded 2007
- CEO N/A
- Website www.minervaneurosciences.com
- Headquarter Massachusetts, United States
- FIGI BBG0067S9Z73
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3476 | CLLS Cellectis S.A. - American Depositary Shares | 3.51 USD | +2.63% | +4.78% | +23.16% | +33.46% | 251.85 M USD | ||
| 3484 | CGEN Compugen Ltd. - Ordinary Shares | 2.62 USD | -5.07% | -2.24% | +14.91% | +87.14% | 247.73 M USD | ||
| 3496 | PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.31 USD | -0.43% | -2.12% | +31.25% | +5.00% | 243.38 M USD | ||
| 3518 | RNA Atrium Therapeutics, Inc. - Common Stock | 13.72 USD | -1.86% | +3.55% | +20.25% | -80.49% | 234.69 M USD |
Frequently asked questions about Minerva Neurosciences, Inc
What is the Minerva Neurosciences, Inc stock price today?
The current price of Minerva Neurosciences, Inc (NERV) is 5.13. Over the past 24 hours, the stock has changed by +8.60%. Follow the NERV chart for real-time price dynamics.
What is the stock ticker of Minerva Neurosciences, Inc?
Minerva Neurosciences, Inc trades under the ticker NERV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Minerva Neurosciences, Inc stock going up?
NERV has changed by +2.40% over the last week, +19.86% over the last month, and +111.98% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Minerva Neurosciences, Inc?
Minerva Neurosciences, Inc currently has a market capitalization of 244.94 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Minerva Neurosciences, Inc earnings last quarter?
Last quarter, Minerva Neurosciences, Inc reported earnings of 0.36 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Minerva Neurosciences, Inc revenue for the last quarter?
Minerva Neurosciences, Inc reported quarterly revenue of -14.35 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Minerva Neurosciences, Inc net income for the last quarter?
Minerva Neurosciences, Inc reported net income of 17.47 M for the last quarter. The previous quarter showed -125.4 M, which means net income changed by +113.93%.
How many employees does Minerva Neurosciences, Inc have?
As of the latest available data, Minerva Neurosciences, Inc has 7 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Minerva Neurosciences, Inc stock?
You can buy Minerva Neurosciences, Inc (NERV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Minerva Neurosciences, Inc stock?
Investing in Minerva Neurosciences, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NERV chart and related analysis on metatrader.com as part of your research.